ArticlePloS one2018

Temozolomide-induced increase of tumorigenicity can be diminished by targeting of mitochondria in in vitro models of patient individual glioblastoma.

Doreen William et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.